Production issues with Pfizer’s injectable version of naloxone, a lifesaving overdose reversal drug, has caused a shortage of the drug, affecting healthcare providers across the country, The Boston ...

While many are excited for the expansion of free nasal naloxone, some of those who pushed for this program are concerned to ...

Since it began more than two decades ago, the opioid epidemic has taken an enormous toll on people’s lives. In 2022 alone, the U.S. Centers for Disease Control estimates that approximately 80,000 ...

The U.S. Food and Drug Administration on Wednesday approved selling naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid treatment drug to be sold ...

Figure illustrates the proportion of Medicaid managed care plans (MCP) in state covering at least one generic injectable or generic or brand intranasal naloxone formulation without any restrictions.

More than 16,000 British Columbians have been fatally poisoned by toxic drugs since a public health emergency was declared in ...

(Reuters) - A high-dose version of the opioid reversal spray naloxone, made by Hikma Pharmaceuticals, did not result in an increased survival rate compared with lower-dose versions of the drug when ...

In the event of an opioid overdose, naloxone can restore normal breath to a person whose breathing has slowed or stopped — potentially saving a life, according to the National Institute on Drug Abuse.

The U.S. Food and Drug Administration on Wednesday approved selling naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid treatment drug to be sold ...